Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy.

Dhakal, Binod; Abedin, Sameem; Fenske, Timothy; Chhabra, Saurabh; Ledeboer, Nathan; Hari, Parameswaran; Hamadani, Mehdi

Dhakal, Binod; Abedin, Sameem; Fenske, Timothy; Chhabra, Saurabh; Ledeboer, Nathan; Hari, Parameswaran; Hamadani, Mehdi.

Afiliação

Dhakal B; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and.
Abedin S; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and.
Fenske T; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and.
Chhabra S; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and.
Ledeboer N; Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI.
Hari P; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and.
Hamadani M; Blood and Marrow Transplant and Cellular Therapy Program, Department of Medicine, and.

Blood ; 138(14): 1278-1281, 2021 10 07.

Article em En | MEDLINE | ID: mdl-34339501

Assuntos

Vacinas contra COVID-19/imunologia; Transplante de Células-Tronco Hematopoéticas; Imunoterapia Adotiva; SARS-CoV-2/imunologia; Vacinação; Idoso; Humanos; Pessoa de Meia-Idade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Vacinação / Transplante de Células-Tronco Hematopoéticas / Vacinas contra COVID-19 / SARS-CoV-2 Limite: Aged / Humans / Middle aged Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google